Xingzheng Global Fund's Xie Shuying: From a global asset allocation perspective, Chinese assets still hold significant attractiveness.

Ask AI · How can Hong Kong-listed stocks like AI and innovative drugs increase their value for global allocation?

Recently, Xie Shuying, fund manager at Xingzheng Global Fund, said that from the perspective of global asset allocation, Chinese assets still have significant appeal. Regarding whether foreign capital will return to A-share markets, she provided two observation angles: first, from the standpoint of capital flows as a share of GDP, there is room for capital to return; second, since this year began, the renminbi has been appreciating at a relatively fast pace. Whether it is previously allocated capital overseas or funds from corporate export businesses that have not yet been converted back into renminbi, as market recognition of the renminbi’s appreciation trend continues to increase, it is expected that this portion of capital may gradually return.

For the Hong Kong stock market, Xie Shuying noted that although market liquidity has continued to be weak since the second half of last year, she believes these issues are stage-specific phenomena rather than a long-term trend. Over a longer time horizon, the market’s current undervaluation in Hong Kong provides stronger downside protection. In addition, the Hong Kong market has some high-quality listings that cannot be allocated in A-shares. Whether in fields such as AI large-scale models, AI applications, or innovative drugs, there are a number of companies with excellent quality. (Pengpai News reporter Ding Xinqing)